SPY457.40+6.90 1.53%
DIA346.61+6.15 1.81%
IXIC15,381.32+127.27 0.83%

--Credit Suisse Lowers Ascendis Pharma's PT to $179 from $185, Updates Model with Q3 Actuals, Skytrofa US Launch; Keeps Outperform Rating

MT Newswires · 11/11/2021 06:26

Please log in to view news